Elevance Health
ELV· Finance· Fiscal year ends in December
CEO pay in FY2025
Gail K. Boudreaux is the CEO of Elevance Health and was paid $22.6M in FY2025 (Dec), up 10%.
PayNo stock prices for these years
Executives5
See all- 1Gail K. BoudreauxPresident and Chief Executive Officer (CEO)FY2025
- 2Mark KayeEVP and Chief Financial Officer (CFO)FY2025
- 3Peter D. HaytaianEVP and President, Carelon and CarelonRxFY2025
- 4Felicia F. NorwoodEVP and Chief Health Benefits OfficerFY2025
- 5Morgan KendrickEVP and President, Commercial and Specialty Health BenefitsFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allElevance Health paid its 5 named executives $51.4M in total in FY2025 (Dec). CEO Gail K. Boudreaux was paid $22.6M of that.
| Name | |||
|---|---|---|---|
| Gail K. BoudreauxPresident and Chief Executive Officer (CEO) | |||
| Mark KayeEVP and Chief Financial Officer (CFO) | |||
| Peter D. HaytaianEVP and President, Carelon and CarelonRx | |||
| Felicia F. NorwoodEVP and Chief Health Benefits Officer | |||
| Morgan KendrickEVP and President, Commercial and Specialty Health Benefits | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Elevance Health. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board11
See all- Lewis Hay, IIIDirector · 12 yr on the boardIndependentAudit, Finance—Paid as an executive
- Antonio F. NeriDirector · 8 yr on the boardIndependentAudit, Governance, Compensation and Talent (Chair)—Paid as an executive
- Gail K. BoudreauxDirector · 8 yr on the boardNot independent—Paid as an executive
- Bahija Jallal, Ph.D.Director · 7 yr on the boardIndependentCompensation and Talent, Governance (Chair)—Paid as an executive
- Deanna D. StrableDirector · 3 yr on the boardIndependentAudit, Governance—Paid as an executive
- Amy W. SchulmanDirector · -1 yr on the boardIndependentAudit, Finance—Paid as an executive
The board of the latest proxy (FY2025).
Shared directors
- CencoraSteven H. Collis1 shared
- TargetGail K. Boudreaux1 shared
Activity
Filings23
See all| Current report | 8-K | May 13, 2026 | — |
| Proxy statement | DEF 14A | Mar 27, 2026 | FY2025 |
| Current report | 8-K | Feb 26, 2026 | — |
| Annual report | 10-K | Feb 6, 2026 | FY2025 |
| Current report | 8-K | Dec 10, 2025 | — |
| Current report | 8-K | Jul 28, 2025 | — |
